Perrigo To Market Generic Commit Lozenge; Agis Buy Helps Build OTC Sales
This article was originally published in The Tan Sheet
Executive Summary
Perrigo expects to start shipping its private-label equivalents to GSK's Commit nicotine lozenges in early March, the company announced Feb. 2
You may also be interested in...
Cough/Cold Sales Shortfall Has Perrigo Looking To Smoking Cessation
Perrigo expects nicotine replacement gum product revenue to compensate in part for lagging winter cough/cold sales in the second half of its fiscal year
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say